Natural Alternatives International (NAII)
Nasdaq Market Closed
Natural Alternatives International Inc. is a nutritional products company that develops and manufactures dietary supplements and related health and wellness products for brand owners. The company works with customers in the United States and overseas, supplying products such as vitamins, minerals, herbal formulas and other supplement formats used by consumer health, sports nutrition and wellness brands.
NAI’s core business is private-label contract manufacturing. In this segment, the company provides formulation, production, packaging and related services to businesses that market supplements under their own brands. This model positions NAI as a business-to-business supplier rather than primarily a consumer-facing supplement label. Its customers can use the company’s manufacturing capacity and technical expertise to bring products to market without operating their own production facilities.
The company also operates a patent and trademark licensing business. This segment generates royalty income and supply-related revenue from license agreements tied to intellectual property used in nutritional and healthcare products. That gives NAI a second, smaller revenue stream alongside its manufacturing operations.
Natural Alternatives International serves a market shaped by consumer demand for preventive health, active lifestyles and nutrition support. Its role in the industry depends on product quality, regulatory compliance, reliable supply and the ability to support changing customer requirements. As a listed small-cap company, NAII offers investors exposure to the dietary supplement manufacturing sector, where performance is influenced by customer concentration, ingredient costs, production efficiency, international demand and broader trends in consumer wellness spending.
Last updated
- Market Cap
- 15.75M
- P/E
- —
- P/FCF
- —
- P/S
- 0.11
- Enterprise Value
- 25.26M
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Address
- 1535 FARADAY AVENUE, CARLSBAD, CA, 92008-7319
CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism
Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 15.75M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 25.26M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.25
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.11
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -17.6
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.18
- EPS
- -2.29
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -9.02M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -22.77%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -9.28%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.3
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.64
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.87
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.24
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 18.4K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 2.51
Income Statement
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Revenue | 35.48M | 34.8M | 37.73M | 33.87M | 28.77M |
| Gross profit | 383K | 2.49M | 4.4M | 3.54M | 1.83M |
| Operating income | -4.01M | -1.85M | 284K | -1.94M | -2.1M |
| EBITDA | -2.82M | -681K | 1.45M | 616K | -961K |
| Net income | -4.31M | -2.55M | -291K | -7.22M | -2.19M |
| Basic EPS | -0.72 | -0.42 | -0.05 | -1.21 | -0.37 |
| Diluted EPS | -0.72 | -0.42 | -0.05 | -1.21 | -0.37 |
Balance Sheet
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total assets | 154.88M | 153.3M | 156.95M | 151.94M | 154.94M |
| Total liabilities | 91.77M | 86.26M | 87.92M | 83.51M | 78.33M |
| Total equity | 63.11M | 67.05M | 69.02M | 68.43M | 76.62M |
| Cash & equivalents | 9.2M | 3.75M | 7.74M | 12.33M | 10.61M |
| Current assets | 64M | 61.52M | 65.05M | 59.28M | 58.52M |
| Current liabilities | 39.13M | 32.85M | 33.9M | 28.8M | 23.31M |
Cash Flow
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating cash flow | 2.5M | -6.33M | -4.02M | 3.35M | 5.99M |
| Investing cash flow | -1.1M | -934K | -1.03M | -1.46M | -802K |
| Financing cash flow | 4.04M | 3.27M | 472K | -176K | -3.24M |
| Change in cash | 5.44M | -3.99M | -4.58M | 1.71M | 1.95M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | S-8 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 10-Q — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | NT 10-Q — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 8-K — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — Ramanathan Guru | View Filing | |
| form 4 | Form 4 — Matherly Laura Kay | View Filing | |
| form 4 | Form 4 — Dunn Alan G | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — Fortin Michael E | View Filing | |
| form 4 | Form 4 — Fortin Michael E | View Filing | |
| form 4 | Form 4 — Fortin Michael E | View Filing | |
| form 4 | Form 4 — WOLF KENNETH | View Filing | |
| form 4 | Form 4 — WOLF KENNETH | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| form 4 | Form 4 — LEDOUX MARK A | View Filing | |
| edgar index | 10-Q — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | SCHEDULE 13G/A — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing | |
| edgar index | 4 — NATURAL ALTERNATIVES INTERNATIONAL INC | View Filing |